Filing step-change
TITANBIO · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-28 · Evidence medium
TITANBIO ended 54.25% on , accelerating from 18.8% quarter-over-quarter.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 54.25 % | 18.8 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.8 % | 15.48 | ▲ |
| REVENUE_GROWTH_YOY | 27.3 % | 58.4 | ▼ |
Cite this
Source: Samhati filing step-change for TITANBIO (2026-09). Observation: TITANBIO ended 54.25% on , accelerating from 18.8% quarter-over-quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/titanbio/q/2026-09
Other periods